SEC Company Response from BlackRock Health Sciences Trust II (BMEZ) (CIK 0001785971) (BMEZ) — Jan 24, 2020
BlackRock Health Sciences Trust II (BMEZ) (CIK 0001785971)
Date: Jan. 24, 2020 · CIK: 0001785971 · Accession: 0001193125-20-014085
AI Filing Summary & Sentiment
File numbers found in text: 333-233373, 811-23466
Show Raw Text
CORRESP 1 filename1.htm BlackRock Health Sciences Trust II Morgan Stanley & Co. LLC 1585 Broadway New York, New York 10036 January 24, 2020 VIA EDGAR Securities and Exchange Commission Division of Investment Management 100 F Street, N.E. Washington, D.C. 20549 Attn.: Deborah L. O’Neal Attorney, Disclosure Review Office BlackRock Health Sciences Trust II Registration Statement on Form N-2 File Nos. 333-233373; 811-23466 Dear Ms. O’Neal: Pursuant to Rule 461 under the Securities Act of 1933, as amended, the undersigned, as representative of the prospective underwriters of the securities covered by the above-captioned Registration Statement, hereby joins in the request of BlackRock Health Sciences Trust II that the effectiveness of the Registration Statement relating to such securities be accelerated so that the Registration Statement will become effective by 12:00 pm, Eastern Time, on January 28, 2020, or as soon thereafter as practicable. [Signature Page Follows] Sincerely, MORGAN STANLEY & CO. LLC As Representative of the several Underwriters By: /s/ Celestina Milner Name: Celestina Milner Title: Executive Director